Sook Ryun Park

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

Atsushi Ohtsu, Manish A. Shah, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2011 · 1.1K citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Sung Hoon Noh, Sook Ryun Park, Han‐Kwang Yang et al. · The Lancet Oncology · 2014 · 1.1K citations · Full text

Medicine, Oncology, Surgery +15

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study

Jianming Xu, Ken Kato, Eric Raymond et al. · The Lancet Oncology · 2023 · 291 citations

Medicine, Oncology, Pharmacology +12

Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3)

Seyoung Seo, Min‐Hee Ryu, Young Soo Park et al. · Gastric Cancer · 2018 · 165 citations · Full text

Medicine, Molecular Medicine, Oncology +10

Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor

Yun-Jae Kim, Gihyeon Kim, Sujeong Kim et al. · Cell Host & Microbe · 2024 · 165 citations · Full text

Life Sciences, Immunology, Oncology +17